CoverageForm 410-K10-Q8-K13D13G13F

CLB Core Laboratories Inc. /De/ - 8-K

Filed Mar 23, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001193125-26-119934
7.019.01

Item 7.01 - Regulation FD Disclosure

111 words

Item 7.01 Regulation FD Disclosure.

On March 23, 2026, Core Laboratories Inc. issued a press release announcing revisions to previously issued earnings guidance for the first quarter of 2026. The full text of the press release is set forth in Exhibit 99.1 attached hereto.

The information in this Report and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.

Item 9.01 - Financial Statements and Exhibits

49 words

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1 Press release issued on March 23, 2026 *

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

* This exhibit is intended to be furnished and shall not be deemed “filed” for purposes of the Exchange Act.